TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 30148388

Group type: EXPERIMENTAL
Intervention: Focusing on honesty in communication for 3 days
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Engaging in specific honest conversations (disclosing personal information)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Engaging in specific honest conversations (sharing negative feedback)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Being kind in communication for 3 days
Number of subjects: 0

Group type: COMPARATOR
Intervention: Being conscious of communication for 3 days
Number of subjects: 0
Study: 26060092

Group type: COMPARATOR
Intervention: Rowing (ROW)
Number of subjects: 13

Group type: COMPARATOR
Intervention: Cycling (CYC)
Number of subjects: 13
Study: 23887932

Group type: EXPERIMENTAL
Intervention: Complicated grief group therapy (CGGT)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Standard group therapy (treatment as usual [TAU])
Number of subjects: 100
Study: 22106987

Group type: EXPERIMENTAL
Intervention: Personalization (mentioning recipient's first name three times in the text) with strong arguments
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Personalization (mentioning recipient's first name three times in the text) with weak arguments
Number of subjects: 120

Group type: COMPARATOR
Intervention: Standard (no personalization) with strong arguments
Number of subjects: 120

Group type: COMPARATOR
Intervention: Standard (no personalization) with weak arguments
Number of subjects: 120
Study: 20357174

Group type: EXPERIMENTAL
Intervention: 54 mg of genistein aglycone daily (n = 71)
Number of subjects: 389

Group type: COMPARATOR
Intervention: Placebo (n = 67)
Number of subjects: 389
Study: 19337553

Group type: EXPERIMENTAL
Intervention: rosuvastatin 10 mg
Number of subjects: 504

Group type: COMPARATOR
Intervention: simvastatin 20 mg
Number of subjects: 504
Study: 15703931

Group type: EXPERIMENTAL
Intervention: FDG-PET in hyperglycaemic DM
Number of subjects: 219

Group type: EXPERIMENTAL
Intervention: FDG-PET in euglycaemic DM
Number of subjects: 219

Group type: EXPERIMENTAL
Intervention: FDG-PET in non-DM
Number of subjects: 219

Group type: EXPERIMENTAL
Intervention: FDG-PET (all DM patients)
Number of subjects: 219
Study: 15317925

Group type: EXPERIMENTAL
Intervention: Previous fracture
Number of subjects: 4292

Group type: EXPERIMENTAL
Intervention: A fall in the last 12 months
Number of subjects: 4292

Group type: EXPERIMENTAL
Intervention: Age (per year increase)
Number of subjects: 4292

Group type: EXPERIMENTAL
Intervention: Low body weight (<58 kg)
Number of subjects: 4292

Group type: EXPERIMENTAL
Intervention: Maternal history of hip fracture
Number of subjects: 4292
Study: 11029334

Group type: EXPERIMENTAL
Intervention: 400 microgram orally inhaled budesonide plus 200 microgram intranasal budesonide (BUD)
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: 10 mg oral montelukast plus 10 mg oral cetirizine (ML + CZ)
Number of subjects: 14
Study: 8610727

Group type: COMPARATOR
Intervention: Subcutaneous administration (usual dose)
Number of subjects: 8

Group type: COMPARATOR
Intervention: Subcutaneous administration (1.75-fold dose)
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Implantable pump therapy (1.75-fold dose)
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Implantable pump therapy (usual dose)
Number of subjects: 8
Study: 1426394

Group type: EXPERIMENTAL
Intervention: Norfloxacin
Number of subjects: 246

Group type: COMPARATOR
Intervention: Chloramphenicol
Number of subjects: 246
Study: 3914839

Group type: EXPERIMENTAL
Intervention: Tamoxifen
Number of subjects: 43

Group type: COMPARATOR
Intervention: Estrogen
Number of subjects: 43

Group type: EXPERIMENTAL
Intervention: Tamoxifen (secondary therapy)
Number of subjects: 43

Group type: COMPARATOR
Intervention: Estrogen (secondary therapy)
Number of subjects: 43
Study: 3695527

Group type: EXPERIMENTAL
Intervention: Chemotherapy with Dacarbazine (DTIC) 200 mg/M2 I.V. daily X 5 every 4 weeks and Estracyt 15 mg/kg orally daily for 1 year
Number of subjects: 82

Group type: EXPERIMENTAL
Intervention: Immunotherapy with TICE BCG 1 ml to an area of scarification near the primary site, every 4 weeks for 1 year
Number of subjects: 82

Group type: COMPARATOR
Intervention: Observation
Number of subjects: 82

Group type: EXPERIMENTAL
Intervention: Histologic status of the regional nodes
Number of subjects: 82
Study: 31119438

Group type: EXPERIMENTAL
Intervention: Airtraq™
Number of subjects: 26

Group type: COMPARATOR
Intervention: GlideScope®
Number of subjects: 26
Study: 29135993

Group type: EXPERIMENTAL
Intervention: Innovator tacrolimus
Number of subjects: 71

Group type: COMPARATOR
Intervention: Generic Hi
Number of subjects: 71

Group type: COMPARATOR
Intervention: Generic Lo
Number of subjects: 71

Group type: EXPERIMENTAL
Intervention: All products
Number of subjects: 71
Study: 26391858

Group type: EXPERIMENTAL
Intervention: Preoperative MR diagnostic work-up (standard preoperative diagnostic work-up + MRC)
Number of subjects: 56

Group type: COMPARATOR
Intervention: Standard preoperative diagnostic work-up
Number of subjects: 56
Study: 23183390

Group type: EXPERIMENTAL
Intervention: High Intensity Interval Exercise (HI‐IE)
Number of subjects: 15

Group type: COMPARATOR
Intervention: Moderate Intensity Continuous Exercise (MI‐CE)
Number of subjects: 15
Study: 21518170

Group type: EXPERIMENTAL
Intervention: Art therapy
Number of subjects: 39

Group type: COMPARATOR
Intervention: Calculation training (Control)
Number of subjects: 39
Study: 17933005

Group type: EXPERIMENTAL
Intervention: Beger procedure
Number of subjects: 40

Group type: COMPARATOR
Intervention: pylorus-preserving Whipple procedure
Number of subjects: 40
Study: 17024871

Group type: EXPERIMENTAL
Intervention: Neoadjuvant chemotherapy
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Neoadjuvant chemoradiotherapy
Number of subjects: 0

Group type: COMPARATOR
Intervention: Postoperative radiation therapy (PORT)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Surgical resection
Number of subjects: 0
Study: 12137243

Group type: EXPERIMENTAL
Intervention: Inhalation challenge with (1‐‐>3)‐beta‐D‐glucan
Number of subjects: 35

Group type: COMPARATOR
Intervention: Saline inhalation challenge
Number of subjects: 35
Study: 9740934

Group type: EXPERIMENTAL
Intervention: Vertical infraclavicular block (VIP1)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Vertical infraclavicular block (VIP2)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Axillary block (AX)
Number of subjects: 0
Study: 8543745

Group type: EXPERIMENTAL
Intervention: Active low allergen diet (milk-, egg-, wheat-, nut-free)
Number of subjects: 115

Group type: COMPARATOR
Intervention: Control diet
Number of subjects: 115
Study: 2220622

Group type: EXPERIMENTAL
Intervention: Verapamil
Number of subjects: 20

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20
Study: 353387

Group type: EXPERIMENTAL
Intervention: Disulfiram implantation
Number of subjects: 20

Group type: COMPARATOR
Intervention: Placebo implantation
Number of subjects: 20
Study: 29119296

Group type: COMPARATOR
Intervention: Steroid injection (1 ml of Depo-Medrol, 40 mg)
Number of subjects: 66

Group type: EXPERIMENTAL
Intervention: Dry needling
Number of subjects: 66
Study: 27491847

Group type: EXPERIMENTAL
Intervention: Case-based learning (CBL)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Simulation exercises (SE)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Control group (didactic teaching only)
Number of subjects: 60
Study: 23331760

Group type: EXPERIMENTAL
Intervention: Effective sun protection messages
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Ineffective sun protection messages
Number of subjects: 0

Group type: COMPARATOR
Intervention: Fear appeal (cancer vs. appearance)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Neutral fear appeal
Number of subjects: 0
Study: 22239915

Group type: EXPERIMENTAL
Intervention: Bilateral constant-current deep brain stimulation (DBS) of the subthalamic nucleus
Number of subjects: 136

Group type: COMPARATOR
Intervention: Control group (delayed stimulation)
Number of subjects: 136

Group type: COMPARATOR
Intervention: Both groups (stimulation and control)
Number of subjects: 136
Study: 19955397

Group type: EXPERIMENTAL
Intervention: Nutritional advice from a brochure
Number of subjects: 195

Group type: EXPERIMENTAL
Intervention: Brochure and lifestyle education by a nutritionist
Number of subjects: 195

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 195
Study: 18672763

Group type: EXPERIMENTAL
Intervention: Shexiang Baoxin Pill (SBP) 2 pills, taken orally three times per day for 6 months
Number of subjects: 200

Group type: COMPARATOR
Intervention: Basic therapy for CHD (anti-platelet, lipid regulating, anti-ischemia)
Number of subjects: 200
Study: 16898535

Group type: EXPERIMENTAL
Intervention: Steroid treatment (60 mg/m2/48h) in children in relapse (Group A, n=24)
Number of subjects: 66

Group type: EXPERIMENTAL
Intervention: Steroid treatment (30 mg/m2/48h) in children in remission (Group B, n=20)
Number of subjects: 66

Group type: COMPARATOR
Intervention: No steroid treatment in children in remission (Group C, n=22)
Number of subjects: 66

Group type: COMPARATOR
Intervention: Healthy controls (n=20)
Number of subjects: 66
Study: 12803733

Group type: EXPERIMENTAL
Intervention: Rosiglitazone 8 mg/day
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Rosiglitazone 4 mg/day
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Rosiglitazone
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 10583422

Group type: EXPERIMENTAL
Intervention: Angiotensin II i.v. for 6 h (1-3 microgram min-1)
Number of subjects: 72

Group type: EXPERIMENTAL
Intervention: Angiotensin II + captopril
Number of subjects: 72

Group type: COMPARATOR
Intervention: Losartan
Number of subjects: 72

Group type: COMPARATOR
Intervention: Captopril
Number of subjects: 72

Group type: COMPARATOR
Intervention: Angiotensin II + losartan
Number of subjects: 72
Study: 8934009

Group type: EXPERIMENTAL
Intervention: Resecting scar tissues, molding the closed glottis, and stenting a patent laryngeal lumen until consolidation
Number of subjects: 0
Study: 2011407

Group type: EXPERIMENTAL
Intervention: Ciprofloxacin (750 mg b.i.d.)
Number of subjects: 142

Group type: COMPARATOR
Intervention: Amoxicillin + clavulanic acid or erythromycin
Number of subjects: 142
Study: 7336474

Group type: EXPERIMENTAL
Intervention: BCG vaccine
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 29671172

Group type: EXPERIMENTAL
Intervention: Whole grain wheat bread (WW diet)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Refined wheat bread (RW diet)
Number of subjects: 50
Study: 24249544

Group type: EXPERIMENTAL
Intervention: High dose trivalent inactivated influenza vaccine (60 µg)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Standard dose trivalent inactivated influenza vaccine (15 µg)
Number of subjects: 50
Study: 22017808

Group type: EXPERIMENTAL
Intervention: Mindfulness-based cognitive therapy plus treatment as usual (MBCT+TAU)
Number of subjects: 205

Group type: COMPARATOR
Intervention: Treatment as usual (TAU)
Number of subjects: 205
Study: 20308699

Group type: EXPERIMENTAL
Intervention: 90‐min daytime nap at 11:30
Number of subjects: 6

Group type: COMPARATOR
Intervention: 90‐min daytime nap at 10:30
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: 1‐h time interval between training and nap
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: 2‐h time interval between training and nap
Number of subjects: 6
Study: 18602634

Group type: EXPERIMENTAL
Intervention: Immediate removal of urethral catheter
Number of subjects: 200
Study: 16277711

Group type: EXPERIMENTAL
Intervention: Drotrecogin alfa (activated)
Number of subjects: 612

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 612
Study: 11910270

Group type: EXPERIMENTAL
Intervention: Metergoline 8 mg
Number of subjects: 16

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Bright artificial light treatment after 2 weeks
Number of subjects: 16
Study: 10850749

Group type: EXPERIMENTAL
Intervention: Propentofylline
Number of subjects: 0

Group type: COMPARATOR
Intervention: Standard care (placebo)
Number of subjects: 0
Study: 9010121

Group type: EXPERIMENTAL
Intervention: Clozapine
Number of subjects: 70

Group type: COMPARATOR
Intervention: Haloperidol
Number of subjects: 70
Study: 1678273

Group type: EXPERIMENTAL
Intervention: Ibopamine 100 mg
Number of subjects: 10

Group type: COMPARATOR
Intervention: Metoclopramide
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Ibopamine and Metoclopramide
Number of subjects: 10
Study: 6190530

Group type: EXPERIMENTAL
Intervention: Pulsion intubation
Number of subjects: 106

Group type: COMPARATOR
Intervention: Retrosternal gastric bypass
Number of subjects: 106
Study: 31791299

Group type: EXPERIMENTAL
Intervention: Increasing the proportion of lower energy options available in targeted food categories (including main meals, snacks, and cold drinks)
Number of subjects: 19

Group type: EXPERIMENTAL
Intervention: Combining increasing the proportion of lower energy options with reducing portion sizes
Number of subjects: 19
Study: 30388670

Group type: EXPERIMENTAL
Intervention: 8-week foot-ankle muscle strength-training program
Number of subjects: 31

Group type: COMPARATOR
Intervention: stretching protocol
Number of subjects: 31
Study: 26681523

Group type: EXPERIMENTAL
Intervention: Ultrasound-guided femoral nerve block
Number of subjects: 16

Group type: COMPARATOR
Intervention: Nerve-stimulator-guided femoral nerve block
Number of subjects: 16
Study: 24831119

Group type: EXPERIMENTAL
Intervention: MoodGYM (cCBT programme)
Number of subjects: 149

Group type: COMPARATOR
Intervention: Waiting list control
Number of subjects: 149
Study: 22748068

Group type: EXPERIMENTAL
Intervention: Remifentanil patient controlled analgesia
Number of subjects: 180000

Group type: COMPARATOR
Intervention: Epidural analgesia
Number of subjects: 180000
Study: 21273714

Group type: EXPERIMENTAL
Intervention: Mineral-enriched mouthrinse
Number of subjects: 14

Group type: COMPARATOR
Intervention: Fluoridated dentifrice
Number of subjects: 14

Group type: COMPARATOR
Intervention: Nonfluoridated dentifrice
Number of subjects: 14
Study: 17919140

Group type: EXPERIMENTAL
Intervention: Specific oral tolerance induction (SOTI)
Number of subjects: 45

Group type: COMPARATOR
Intervention: Elimination diet (Control)
Number of subjects: 45
Study: 16199445

Group type: EXPERIMENTAL
Intervention: Formal education about informed consent (one-hour interactive intervention consisting of a lecture, video, and small-group discussion)
Number of subjects: 27

Group type: COMPARATOR
Intervention: Wait-list control group (no intervention during the study period)
Number of subjects: 27
Study: 12114234

Group type: EXPERIMENTAL
Intervention: Tension-free vaginal tape
Number of subjects: 344

Group type: COMPARATOR
Intervention: Colposuspension
Number of subjects: 344
Study: 10408485

Group type: EXPERIMENTAL
Intervention: Desmopressin
Number of subjects: 203

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 203

Group type: COMPARATOR
Intervention: Untreated control
Number of subjects: 203
Study: 8433578

Group type: EXPERIMENTAL
Intervention: Prenatal and infancy nurse home visitation
Number of subjects: 400
Study: 3593481

Group type: EXPERIMENTAL
Intervention: Acute alcohol consumption (0.4 g/kg orally)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Standard (75 g) glucose tolerance test
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Feeding or fasting
Number of subjects: 0
Study: 29148008

Group type: EXPERIMENTAL
Intervention: Supervised forearm exercises 6 weeks pre-operatively
Number of subjects: 40

Group type: COMPARATOR
Intervention: No exercise (control group)
Number of subjects: 40
Study: 27697397

Group type: EXPERIMENTAL
Intervention: 2 implant‐supported‐overdentures on two tissue‐level implants
Number of subjects: 52

Group type: COMPARATOR
Intervention: 4 implant‐supported‐overdentures on four tissue‐level implants
Number of subjects: 52

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 52
Study: 24818861

Group type: EXPERIMENTAL
Intervention: Cognitive behavioural treatment programme (CONECSI)
Number of subjects: 29
Study: 22566279

Group type: EXPERIMENTAL
Intervention: Group acceptance and commitment therapy (ACT) informed stress management intervention
Number of subjects: 56

Group type: COMPARATOR
Intervention: Waitlist control group
Number of subjects: 56
Study: 20976813

Group type: EXPERIMENTAL
Intervention: Vaginal ultrasound measurement of bladder wall thickness
Number of subjects: 125

Group type: EXPERIMENTAL
Intervention: Abdominal ultrasound measurement of bladder wall thickness
Number of subjects: 125

Group type: EXPERIMENTAL
Intervention: Perineal ultrasound measurement of bladder wall thickness
Number of subjects: 125

Group type: COMPARATOR
Intervention: Comparison of abdominal and perineal ultrasound measurements
Number of subjects: 125
Study: 18926388

Group type: EXPERIMENTAL
Intervention: Contrast stress echocardiography (CSE) with regional diastolic contour abnormalities (RDCAs)
Number of subjects: 106

Group type: COMPARATOR
Intervention: Contrast stress echocardiography (CSE) without RDCAs
Number of subjects: 106
Study: 16485515

Group type: EXPERIMENTAL
Intervention: Perindopril 8 mg/day for 1 year
Number of subjects: 100

Group type: COMPARATOR
Intervention: Control (not specified)
Number of subjects: 100
Study: 15458147

Group type: EXPERIMENTAL
Intervention: Eyeglass displays providing visual stimulation (projecting a feeling of watching a fifty-two-inch television screen)
Number of subjects: 72

Group type: COMPARATOR
Intervention: Control group (no visual stimulation)
Number of subjects: 72
Study: 10534683

Group type: EXPERIMENTAL
Intervention: Blood cardioplegia
Number of subjects: 47

Group type: COMPARATOR
Intervention: Crystalloid cardioplegia
Number of subjects: 47
Study: 9279673

Group type: EXPERIMENTAL
Intervention: Diclofenac sodium 0.1% ophthalmic solution
Number of subjects: 117

Group type: COMPARATOR
Intervention: Flurbiprofen 0.03% ophthalmic solution
Number of subjects: 117

Group type: COMPARATOR
Intervention: Indomethacin 1.0% ophthalmic solution
Number of subjects: 117
Study: 1702582

Group type: EXPERIMENTAL
Intervention: Consensus interferon
Number of subjects: 55

Group type: EXPERIMENTAL
Intervention: Interferon alfa‐2a
Number of subjects: 55

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 55

Group type: EXPERIMENTAL
Intervention: Adjunctive therapy
Number of subjects: 55
Study: 6853874

Group type: EXPERIMENTAL
Intervention: Affective imagery training group
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Attention group
Number of subjects: 30

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 30
Study: 31126557

Group type: EXPERIMENTAL
Intervention: Nigella sativa (2 gram/day)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Placebo (starch, 2 gram/day)
Number of subjects: 50
Study: 27848050

Group type: EXPERIMENTAL
Intervention: Sentinel-node-based management (SNBM)
Number of subjects: 1088

Group type: COMPARATOR
Intervention: Routine axillary clearance (RAC)
Number of subjects: 1088
Study: 25899888

Group type: EXPERIMENTAL
Intervention: High ligation and stripping (HL + S)
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: High ligation and endovenous laser ablation (HL + EVLA)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Control group (not explicitly mentioned)
Number of subjects: 100
Study: 24998653

Group type: EXPERIMENTAL
Intervention: Atorvastatin (20 mg q.d for 1 year)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 60
Study: 22402864

Group type: EXPERIMENTAL
Intervention: Pentoxifylline (PTX) 20 mg/kg/day for 12 months
Number of subjects: 64

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 64

Group type: EXPERIMENTAL
Intervention: Pentoxifylline (PTX)
Number of subjects: 64
Study: 19901139

Group type: EXPERIMENTAL
Intervention: Low-fat (LF) diet
Number of subjects: 106

Group type: COMPARATOR
Intervention: Very low-carbohydrate (LC) diet
Number of subjects: 106

Group type: EXPERIMENTAL
Intervention: Both diets
Number of subjects: 106
Study: 17973129

Group type: EXPERIMENTAL
Intervention: Cast gold partial crowns (CGPC)
Number of subjects: 28

Group type: COMPARATOR
Intervention: Partial ceramic crowns (PCC)
Number of subjects: 28
Study: 15133565

Group type: EXPERIMENTAL
Intervention: First group (open drainage, sealing devitalized material after 1 day)
Number of subjects: 173

Group type: EXPERIMENTAL
Intervention: Second group (enlarging exposure site, drainage for several minutes, sealing devitalized material)
Number of subjects: 173

Group type: EXPERIMENTAL
Intervention: Third group (pulpectomy)
Number of subjects: 173
Study: 11248182

Group type: EXPERIMENTAL
Intervention: Cytokine therapy (growth factor treatment)
Number of subjects: 54
Study: 9794972

Group type: EXPERIMENTAL
Intervention: Intense pediatric and family support
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 0
Study: 7660056

Group type: EXPERIMENTAL
Intervention: Non-linear hearing aid (test HA)
Number of subjects: 32

Group type: COMPARATOR
Intervention: Linear hearing aid (control HA)
Number of subjects: 32
Study: 2402210

Group type: EXPERIMENTAL
Intervention: 40% VO2max exercise for 15 min
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: 70% VO2max exercise for 15 min
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: 100% VO2max exercise test
Number of subjects: 16

Group type: COMPARATOR
Intervention: Rest
Number of subjects: 16
Study: 7352521

Group type: EXPERIMENTAL
Intervention: Betamethasone
Number of subjects: 137

Group type: COMPARATOR
Intervention: Control (placebo)
Number of subjects: 137
Study: 30424684

Group type: EXPERIMENTAL
Intervention: High‐intensity circuit training (HICT)
Number of subjects: 22

Group type: EXPERIMENTAL
Intervention: Functional progressive resistance training (PRT)
Number of subjects: 22
Study: 29084656

Group type: EXPERIMENTAL
Intervention: Enhanced statin lipid-lowering regimen
Number of subjects: 0

Group type: COMPARATOR
Intervention: Standard regimen
Number of subjects: 0
Study: 26081328

Group type: EXPERIMENTAL
Intervention: Ibuprofen (200-400 mg/day) + Tizanidine (2-4 mg/day) + Anvifen (750 mg/day) for 8 weeks
Number of subjects: 50

Group type: COMPARATOR
Intervention: Ibuprofen (200-400 mg/day) + Tizanidine (2-4 mg/day)
Number of subjects: 50
Study: 25040039

Group type: EXPERIMENTAL
Intervention: AQX-1125 (450 mg daily)
Number of subjects: 22
Study: 22777369

Group type: EXPERIMENTAL
Intervention: Estradiol-releasing vaginal ring
Number of subjects: 65

Group type: COMPARATOR
Intervention: Placebo vaginal ring
Number of subjects: 65

Group type: COMPARATOR
Intervention: Control without vaginal ring
Number of subjects: 65

Group type: EXPERIMENTAL
Intervention: All groups
Number of subjects: 65
Study: 19916252

Group type: EXPERIMENTAL
Intervention: Ropivacaine 0.375% (20 mL)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Placebo (saline, 20 mL)
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Ropivacaine 0.375%
Number of subjects: 100

Group type: COMPARATOR
Intervention: Placebo (saline)
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Ropivacaine 0.375% and Placebo
Number of subjects: 100